BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 33737930)

  • 1. Translational Research in Vitiligo.
    Katz EL; Harris JE
    Front Immunol; 2021; 12():624517. PubMed ID: 33737930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the PD-1/PD-L1 Axis in Human Vitiligo.
    Willemsen M; Melief CJM; Bekkenk MW; Luiten RM
    Front Immunol; 2020; 11():579022. PubMed ID: 33240267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the NKG2D in Vitiligo.
    Plaza-Rojas L; Guevara-Patiño JA
    Front Immunol; 2021; 12():624131. PubMed ID: 33717132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding mechanisms of autoimmunity through translational research in vitiligo.
    Strassner JP; Harris JE
    Curr Opin Immunol; 2016 Dec; 43():81-88. PubMed ID: 27764715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress of vitiligo repigmentation: from oxidative stress to autoimmunity.
    Yu T; Wu Y; Lu Z
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):147-151. PubMed ID: 38678613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines: the yin and yang of vitiligo pathogenesis.
    Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
    Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical induced pathognomonic features observed in human vitiligo are mediated through miR-2909 RNomics pathway.
    Kaushik H; Kaul D; Kumaran MS; Parsad D
    J Dermatol Sci; 2020 Nov; 100(2):92-98. PubMed ID: 33039241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo: interplay between oxidative stress and immune system.
    Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
    Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity.
    Wang Y; Li S; Li C
    Med Sci Monit; 2019 Feb; 25():1017-1023. PubMed ID: 30723188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Concise Review on the Role of Endoplasmic Reticulum Stress in the Development of Autoimmunity in Vitiligo Pathogenesis.
    Jadeja SD; Mayatra JM; Vaishnav J; Shukla N; Begum R
    Front Immunol; 2020; 11():624566. PubMed ID: 33613564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff.
    Boissy RE; Spritz RA
    Exp Dermatol; 2009 Jul; 18(7):583-5. PubMed ID: 19320739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
    Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
    J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell responses against 4-tert-butylphenol-exposed pigmented cells in a patient with occupational vitiligo.
    Vrijman C; Willemsen KJ; Tjin EPM; Kammeyer A; van den Boorn JG; van der Veen JPW; Jungbauer FHW; Kardaun SH; Luiten RM
    Br J Dermatol; 2019 Aug; 181(2):387-388. PubMed ID: 30719700
    [No Abstract]   [Full Text] [Related]  

  • 17. Programmed cell death protein 1 and vitiligo.
    Lin X; Meng X; Song Z
    Int J Dermatol; 2019 Sep; 58(9):1102-1103. PubMed ID: 31175670
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of tumor necrosis factor-α in the pathogenesis of vitiligo.
    Camara-Lemarroy CR; Salas-Alanis JC
    Am J Clin Dermatol; 2013 Oct; 14(5):343-50. PubMed ID: 23912226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo Pathogenesis and Emerging Treatments.
    Rashighi M; Harris JE
    Dermatol Clin; 2017 Apr; 35(2):257-265. PubMed ID: 28317534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.
    Toosi S; Orlow SJ; Manga P
    J Invest Dermatol; 2012 Nov; 132(11):2601-9. PubMed ID: 22696056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.